sangeetha palakurthi on fda approval of atezolizumab in nsclc
Published 8 years ago • 387 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
1:27
fda approval of atezolizumab for nsclc
-
1:37
sangeetha palakurthi on strategies for managing resistance to osimertinib in patients with nsclc
-
7:05
the fda approval of atezolizumab in bladder cancer
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
6:27
fda approval in nsclc, and ema regulatory advances in pancreatic cancer, nhl, and cll
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
4:48
gefitinib approved for nsclc, atezolizumab shrinks bladder tumors, and more
-
1:28
dr. randy sweis on impact of atezolizumab approval in bladder cancer
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc
-
1:45
dr. chandra belani on atezolizumab in nsclc
-
0:26
periodical medical camp at orphange in rampally village.
-
1:12
dr. drilon on ret rearrangements in nsclc
-
0:58
post-covid centers - dr. latha yedlapalli & dr. venkat yedlapalli (internal medicine specialists)
-
1:50
pd-l1 agents in the treatment of nsclc
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning